Wann sind Pflaster, Pens oder Pumpen eine sinnvolle Ergänzung zur oralen Therapie?

Monika Pötter‐Nerger(Universität Hamburg), Carsten Buhmann(Universität Hamburg), Ines Goerendt(Universität Hamburg), Christian Gerloff(Universität Hamburg), Ute Hidding(Universität Hamburg), Peter Ludewig(Universität Hamburg)
InFo Neurologie + Psychiatrie
December 1, 2014
10.1007/s15005-014-1062-5
Cited by 0

Related Papers

Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
|The Lancet Neurology|2020|1.4k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Temporal and Spatial Dynamics of Cerebral Immune Cell Accumulation in Stroke
|Stroke|2009|1.1k
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study
|The Lancet Neurology|2011|587
Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke
|Blood|2012|468